Jacobson Mark L.

CIK 00018058121 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001805812

Recent Transactions

47 trades

Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-26$2.85/sh+35,378→ 35,378 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2026-02-26+19,663→ 19,663 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-02-26−35,378→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-26$161.88/sh−35,378→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-09-22−10,000→ 35,378 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-22$2.85/sh+10,000→ 10,000 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-22$115.96/sh−10,000→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-16$4.85/sh+15,000→ 40,000 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-16$116.19/sh−5,783→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-09-16−15,000→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-16$114.23/sh−40,000→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-09-16−25,000→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-16$4.95/sh+25,000→ 25,000 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-06-09−25,000→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-06-09$8.02/sh+25,000→ 30,783 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-06-09$110.44/sh−25,000→ 5,783 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-05-28−20,000→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-28$6.47/sh+20,000→ 25,783 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-28$103.45/sh−20,000→ 5,783 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-05-27−20,673→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-27$104.66/sh−20,673→ 5,783 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-27$6.47/sh+20,673→ 26,456 total
Award
Axsome Therapeutics, Inc.$AXSM
Performance Stock Units
2025-02-24+10,769→ 10,769 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2025-02-21+10,875→ 10,875 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-02-21+10,769→ 10,769 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-08-09$84.26/sh−47,739→ 5,783 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-08-09−47,739→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-08-09$4.04/sh+47,739→ 53,522 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-05-29$1.30/sh+13,693→ 13,693 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-05-29$74.31/sh−7,910→ 5,783 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-05-29−13,693→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-04-01$77.24/sh−24,662→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-04-01$1.30/sh+24,662→ 24,662 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-04-01−24,662→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2024-02-27+18,027→ 18,027 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2024-02-27+32,825→ 32,825 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2023-03-02+23,491→ 23,491 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2023-03-02+41,424→ 41,424 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2022-03-04+47,990→ 47,990 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2022-03-04+89,405→ 89,405 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2021-11-12+41,638→ 41,638 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2021-03-05+22,163→ 22,163 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2021-03-05+41,638→ 41,638 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2020-03-17+14,767→ 14,767 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2020-03-17+60,880→ 60,880 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2020-03-17+48,237→ 48,237 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2020-03-17+18,645→ 18,645 total

Companies

Axsome Therapeutics, Inc.
Chief Operating Officer
$AXSM

Recent Filings

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov